Experienced Microbiome and Bacterial CDMO for Clinical Manufacturing

List Labs' California facility supports clinical manufacturing as an experienced microbial CDMO, with over 45 years of expertise producing bacterial-derived drugs including live biotherapeutic products (LBPs), recombinant proteins, and polysaccharides through Phase II.

Clinical Manufacturing

California Manufacturing Facility from an Experienced Microbiome CDMO

List Labs’ clinical manufacturing facility has:

26,921 sq. ft. Facility
7 GMP Manufacturing Suites (2 ISO7 and 5 ISO8)
Designed for up to BSL3 and Spore Formers
Cultivated >100 Bacterial Species
Produced >100 Different Type of Bacterial Products
500L Volume Capacity with 500L Sartorius Single Use Stirred Tank Reactor and ÄKTA ReadyFlux
Single Use and Stainless Steel Fermenter Options
Manufactured >30 GMP Products

List Labs’ GMP Products by the Numbers

>300 Product Types Manufactured
>100 Reagent Grade Products
168 GMP Product Lots
80 Drug Substances
35 Drug Products
19 Master and Working Cell Banks
26 Placebos
8 Vehicles
34 Client Projects
2 Client Products in Phase 3 Clinical Trials
2 Client Products in Commercial Production

Overview of Manufacturing Capabilities

With an unparalleled legacy of expertise in LBP manufacturing, our California facility offers development and clinical-scale manufacturing of a range of products:

GMP Products
Live Biotherapeutic Products
Bacterial Toxins and Polysaccharides
Recombinant Proteins
Toxoids
FRET Peptides, Native Substrate
Vaccine Carrier Proteins & Adjuvants
Antibodies

Commercial Facility Coming Soon

Learn more about our vision to add commercial manufacturing at a new site.